nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—PDE6G—optic choroid—ocular cancer	0.182	0.342	CbGeAlD
Vardenafil—PDE6H—pineal body—ocular cancer	0.125	0.235	CbGeAlD
Vardenafil—PDE6H—eye—ocular cancer	0.038	0.0714	CbGeAlD
Vardenafil—PDE6H—retina—ocular cancer	0.0377	0.0708	CbGeAlD
Vardenafil—PDE6G—eye—ocular cancer	0.0366	0.0687	CbGeAlD
Vardenafil—PDE6G—retina—ocular cancer	0.0363	0.0681	CbGeAlD
Vardenafil—PDE11A—epithelium—ocular cancer	0.0348	0.0653	CbGeAlD
Vardenafil—PDE5A—eye—ocular cancer	0.0145	0.0272	CbGeAlD
Vardenafil—PDE5A—retina—ocular cancer	0.0143	0.0269	CbGeAlD
Vardenafil—PDE5A—epithelium—ocular cancer	0.0132	0.0248	CbGeAlD
Vardenafil—PDE10A—Signaling Pathways—SAG—ocular cancer	0.00159	0.00341	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—GNA11—ocular cancer	0.00158	0.00339	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—E2F5—ocular cancer	0.00158	0.00338	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—E2F4—ocular cancer	0.00155	0.00332	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—RBL1—ocular cancer	0.00152	0.00325	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—HDAC1—ocular cancer	0.0015	0.0032	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—CDK2—ocular cancer	0.00149	0.00319	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—GNAQ—ocular cancer	0.00147	0.00315	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—E2F5—ocular cancer	0.00145	0.0031	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—GNA11—ocular cancer	0.00144	0.00308	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—E2F4—ocular cancer	0.00142	0.00303	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—GNA11—ocular cancer	0.00141	0.00302	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—E2F5—ocular cancer	0.00141	0.00302	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—RBL1—ocular cancer	0.00139	0.00297	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—E2F4—ocular cancer	0.00138	0.00296	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—RBL1—ocular cancer	0.00135	0.0029	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—GNAQ—ocular cancer	0.00134	0.00286	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—CDK2—ocular cancer	0.00133	0.00284	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—CDK2—ocular cancer	0.00133	0.00284	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—E2F3—ocular cancer	0.00132	0.00282	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—GNAQ—ocular cancer	0.00131	0.00281	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—GNA11—ocular cancer	0.00128	0.00274	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MAML2—ocular cancer	0.00127	0.00272	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—MDM2—ocular cancer	0.00125	0.00268	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TFDP1—ocular cancer	0.00122	0.00262	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—E2F3—ocular cancer	0.0012	0.00258	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—GNAQ—ocular cancer	0.00119	0.00255	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—MDM2—ocular cancer	0.00118	0.00252	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—E2F3—ocular cancer	0.00117	0.00251	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—MDM2—ocular cancer	0.00117	0.00251	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—MDM2—ocular cancer	0.00117	0.0025	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—MDM2—ocular cancer	0.00116	0.00248	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SAG—ocular cancer	0.00115	0.00247	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—CDKN1B—ocular cancer	0.00114	0.00245	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—GNA11—ocular cancer	0.00113	0.00242	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TFDP1—ocular cancer	0.00112	0.0024	CbGpPWpGaD
Vardenafil—PDE6G—Signaling by Wnt—EP300—ocular cancer	0.00111	0.00238	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—MDM2—ocular cancer	0.00109	0.00234	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—MDM2—ocular cancer	0.00109	0.00234	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TFDP1—ocular cancer	0.00109	0.00234	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—MDM2—ocular cancer	0.00108	0.00232	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—CDKN1B—ocular cancer	0.00108	0.0023	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—MDM2—ocular cancer	0.00107	0.0023	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—CDKN1B—ocular cancer	0.00107	0.00229	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—MDM2—ocular cancer	0.00107	0.00229	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—CDKN1B—ocular cancer	0.00106	0.00228	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—CDKN1B—ocular cancer	0.00106	0.00227	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—CDKN1A—ocular cancer	0.00106	0.00226	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—GNAQ—ocular cancer	0.00105	0.00225	CbGpPWpGaD
Vardenafil—PDE1B—Disease—E2F5—ocular cancer	0.00102	0.00218	CbGpPWpGaD
Vardenafil—PDE1B—G Protein Signaling Pathways—HRAS—ocular cancer	0.001	0.00215	CbGpPWpGaD
Vardenafil—PDE1B—Disease—E2F4—ocular cancer	0.000999	0.00214	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—CDKN1B—ocular cancer	0.000997	0.00213	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—CDKN1B—ocular cancer	0.000997	0.00213	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—CDKN1A—ocular cancer	0.000992	0.00212	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—CDKN1B—ocular cancer	0.000988	0.00211	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—CDKN1A—ocular cancer	0.000987	0.00211	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—CDKN1A—ocular cancer	0.000983	0.0021	CbGpPWpGaD
Vardenafil—PDE1B—Disease—RPL39—ocular cancer	0.00098	0.0021	CbGpPWpGaD
Vardenafil—PDE1B—Disease—RBL1—ocular cancer	0.00098	0.0021	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—CDKN1B—ocular cancer	0.000979	0.0021	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—CDKN1A—ocular cancer	0.000978	0.00209	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—CDKN1B—ocular cancer	0.000975	0.00209	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MAML2—ocular cancer	0.000973	0.00208	CbGpPWpGaD
Vardenafil—PDE6G—Signaling by Wnt—MYC—ocular cancer	0.000969	0.00207	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—MDM2—ocular cancer	0.000967	0.00207	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—HDAC1—ocular cancer	0.000948	0.00203	CbGpPWpGaD
Vardenafil—PDE6G—Disease—HDAC1—ocular cancer	0.000929	0.00199	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—CDKN1A—ocular cancer	0.00092	0.00197	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—CDKN1A—ocular cancer	0.00092	0.00197	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—CDKN1A—ocular cancer	0.000912	0.00195	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—CDKN1A—ocular cancer	0.000904	0.00193	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—CDKN1A—ocular cancer	0.0009	0.00193	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MAML2—ocular cancer	0.00089	0.0019	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	0.000883	0.00189	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAML2—ocular cancer	0.000867	0.00186	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—GNA11—ocular cancer	0.000849	0.00182	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—EP300—ocular cancer	0.000836	0.00179	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CDKN2B—ocular cancer	0.000833	0.00178	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.000815	0.00174	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SAG—ocular cancer	0.000807	0.00173	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TFDP1—ocular cancer	0.00079	0.00169	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—GNAQ—ocular cancer	0.000789	0.00169	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—GNA11—ocular cancer	0.000776	0.00166	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—GNA11—ocular cancer	0.000756	0.00162	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—EP300—ocular cancer	0.000745	0.0016	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—EP300—ocular cancer	0.000745	0.0016	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—MDM2—ocular cancer	0.000744	0.00159	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—TGFB1—ocular cancer	0.000727	0.00156	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—GNAQ—ocular cancer	0.000722	0.00154	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—GNA11—ocular cancer	0.000715	0.00153	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—E2F5—ocular cancer	0.000714	0.00153	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HDAC1—ocular cancer	0.000711	0.00152	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—GNAQ—ocular cancer	0.000703	0.00151	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—E2F4—ocular cancer	0.0007	0.0015	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.000688	0.00147	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RBL1—ocular cancer	0.000686	0.00147	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—CDKN1B—ocular cancer	0.000679	0.00145	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—CDK2—ocular cancer	0.000672	0.00144	CbGpPWpGaD
Vardenafil—PDE6G—Signaling by Wnt—AKT1—ocular cancer	0.000672	0.00144	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—GNAQ—ocular cancer	0.000664	0.00142	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HDAC1—ocular cancer	0.00065	0.00139	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—GNA11—ocular cancer	0.000649	0.00139	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—TGFB1—ocular cancer	0.000648	0.00139	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TGFB1—ocular cancer	0.000648	0.00139	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—HRAS—ocular cancer	0.000646	0.00138	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—HRAS—ocular cancer	0.000643	0.00138	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—HRAS—ocular cancer	0.00064	0.00137	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CDKN2B—ocular cancer	0.000637	0.00136	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—HRAS—ocular cancer	0.000637	0.00136	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HDAC1—ocular cancer	0.000634	0.00136	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MAML2—ocular cancer	0.000627	0.00134	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—CDKN1A—ocular cancer	0.000627	0.00134	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.000607	0.0013	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—GNAQ—ocular cancer	0.000603	0.00129	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—HRAS—ocular cancer	0.000599	0.00128	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—HRAS—ocular cancer	0.000599	0.00128	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—TP53—ocular cancer	0.000598	0.00128	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—E2F3—ocular cancer	0.000595	0.00127	CbGpPWpGaD
Vardenafil—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000594	0.00127	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—HRAS—ocular cancer	0.000594	0.00127	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000588	0.00126	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—HRAS—ocular cancer	0.000586	0.00125	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—E2F1—ocular cancer	0.000585	0.00125	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CDKN2B—ocular cancer	0.000583	0.00125	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PSPH—ocular cancer	0.00058	0.00124	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—HRAS—ocular cancer	0.000572	0.00123	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—AKT1—ocular cancer	0.000571	0.00122	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CDKN2B—ocular cancer	0.000568	0.00122	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—AKT1—ocular cancer	0.000568	0.00122	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—AKT1—ocular cancer	0.000565	0.00121	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—AKT1—ocular cancer	0.000562	0.0012	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TFDP1—ocular cancer	0.000553	0.00118	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—E2F1—ocular cancer	0.000535	0.00115	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TP53—ocular cancer	0.000533	0.00114	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—TP53—ocular cancer	0.000533	0.00114	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000531	0.00114	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—AKT1—ocular cancer	0.000529	0.00113	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—AKT1—ocular cancer	0.000529	0.00113	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—AKT1—ocular cancer	0.000524	0.00112	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—E2F1—ocular cancer	0.000522	0.00112	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.00052	0.00111	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—AKT1—ocular cancer	0.000517	0.00111	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—HRAS—ocular cancer	0.00051	0.00109	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—HRAS—ocular cancer	0.00051	0.00109	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—AKT1—ocular cancer	0.000505	0.00108	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000468	0.001	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MDM2—ocular cancer	0.000462	0.000989	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HDAC1—ocular cancer	0.000459	0.000982	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—AKT1—ocular cancer	0.00045	0.000964	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—AKT1—ocular cancer	0.00045	0.000964	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAML2—ocular cancer	0.000439	0.000941	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MDM2—ocular cancer	0.000424	0.000908	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CDKN1B—ocular cancer	0.000422	0.000903	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDKN2B—ocular cancer	0.000411	0.00088	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—HRAS—ocular cancer	0.000408	0.000874	CbGpPWpGaD
Vardenafil—PDE6G—Disease—CDKN1A—ocular cancer	0.000389	0.000833	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CDKN1B—ocular cancer	0.000387	0.000829	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GNA11—ocular cancer	0.000383	0.000821	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—EP300—ocular cancer	0.000378	0.000809	CbGpPWpGaD
Vardenafil—PDE6G—Disease—EP300—ocular cancer	0.00037	0.000793	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—AKT1—ocular cancer	0.00036	0.000771	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CDKN1A—ocular cancer	0.000357	0.000765	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GNAQ—ocular cancer	0.000356	0.000763	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MDM2—ocular cancer	0.000354	0.000757	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—EP300—ocular cancer	0.00034	0.000728	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—HRAS—ocular cancer	0.000328	0.000703	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TGFB1—ocular cancer	0.000328	0.000703	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MDM2—ocular cancer	0.000323	0.000692	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CDKN1B—ocular cancer	0.000323	0.000691	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MYC—ocular cancer	0.000323	0.000691	CbGpPWpGaD
Vardenafil—PDE6G—Disease—TGFB1—ocular cancer	0.000322	0.000689	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HDAC1—ocular cancer	0.000321	0.000688	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—AKT1—ocular cancer	0.000319	0.000684	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MDM2—ocular cancer	0.000315	0.000675	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCND1—ocular cancer	0.000308	0.000659	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CDKN1A—ocular cancer	0.000298	0.000638	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CDKN1B—ocular cancer	0.000295	0.000632	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—HRAS—ocular cancer	0.000293	0.000627	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AKT1—ocular cancer	0.00029	0.000621	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN2B—ocular cancer	0.000288	0.000616	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CDKN1B—ocular cancer	0.000288	0.000616	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AKT1—ocular cancer	0.000285	0.000609	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EP300—ocular cancer	0.000284	0.000607	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCND1—ocular cancer	0.000282	0.000603	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCND1—ocular cancer	0.000275	0.000588	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CDKN1A—ocular cancer	0.000273	0.000583	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TP53—ocular cancer	0.00027	0.000579	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PSPH—ocular cancer	0.00027	0.000577	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CDKN1A—ocular cancer	0.000266	0.000569	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—E2F1—ocular cancer	0.000264	0.000566	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EP300—ocular cancer	0.000259	0.000555	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—HRAS—ocular cancer	0.000259	0.000553	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AKT1—ocular cancer	0.000259	0.000553	CbGpPWpGaD
Vardenafil—PDE6G—Disease—HRAS—ocular cancer	0.000253	0.000543	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EP300—ocular cancer	0.000253	0.000541	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MYC—ocular cancer	0.000247	0.000529	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MDM2—ocular cancer	0.000247	0.000529	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFB1—ocular cancer	0.000246	0.000528	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—HRAS—ocular cancer	0.000233	0.000498	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—AKT1—ocular cancer	0.000228	0.000489	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MDM2—ocular cancer	0.000228	0.000488	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MYC—ocular cancer	0.000226	0.000484	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDKN1B—ocular cancer	0.000226	0.000483	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFB1—ocular cancer	0.000225	0.000483	CbGpPWpGaD
Vardenafil—PDE6G—Disease—AKT1—ocular cancer	0.000224	0.000479	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MYC—ocular cancer	0.00022	0.000471	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFB1—ocular cancer	0.00022	0.00047	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDKN1B—ocular cancer	0.000208	0.000446	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDKN1A—ocular cancer	0.000208	0.000446	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AKT1—ocular cancer	0.000206	0.00044	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TP53—ocular cancer	0.000203	0.000434	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—EP300—ocular cancer	0.000198	0.000424	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HRAS—ocular cancer	0.000194	0.000415	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDKN1A—ocular cancer	0.000192	0.000411	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TP53—ocular cancer	0.000186	0.000397	CbGpPWpGaD
Vardenafil—PDE1B—Disease—EP300—ocular cancer	0.000183	0.000392	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GNA11—ocular cancer	0.000183	0.000391	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TP53—ocular cancer	0.000181	0.000387	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HRAS—ocular cancer	0.000177	0.00038	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HRAS—ocular cancer	0.000173	0.00037	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AKT1—ocular cancer	0.000171	0.000367	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GNAQ—ocular cancer	0.00017	0.000363	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MDM2—ocular cancer	0.00016	0.000342	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MYC—ocular cancer	0.000159	0.000341	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFB1—ocular cancer	0.000159	0.00034	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AKT1—ocular cancer	0.000157	0.000335	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT1—ocular cancer	0.000153	0.000327	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HRAS—ocular cancer	0.000148	0.000318	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN1B—ocular cancer	0.000146	0.000312	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT1—ocular cancer	0.000144	0.000309	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCND1—ocular cancer	0.000139	0.000298	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—HRAS—ocular cancer	0.000136	0.00029	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN1A—ocular cancer	0.000135	0.000288	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT1—ocular cancer	0.000131	0.00028	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EP300—ocular cancer	0.000128	0.000274	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HRAS—ocular cancer	0.000125	0.000268	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT1—ocular cancer	0.00012	0.000256	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MYC—ocular cancer	0.000112	0.000239	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFB1—ocular cancer	0.000111	0.000238	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT1—ocular cancer	0.000111	0.000237	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TP53—ocular cancer	9.17e-05	0.000196	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HRAS—ocular cancer	8.77e-05	0.000188	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GNA11—ocular cancer	8.49e-05	0.000182	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GNAQ—ocular cancer	7.89e-05	0.000169	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT1—ocular cancer	7.74e-05	0.000166	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—EP300—ocular cancer	6.1e-05	0.000131	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKT1—ocular cancer	3.69e-05	7.89e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—EP300—ocular cancer	2.84e-05	6.07e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKT1—ocular cancer	1.71e-05	3.67e-05	CbGpPWpGaD
